Enanta Pharmaceuticals Aktie | Enanta Pharmaceuticals Aktie Aktienkurs Charts Comdirect Informer

Perry Berry

20 Nov, 2021

The firm also conducts research in human. Februar seine nächste Gewinnrunde.

Enanta Pharmaceuticals Inc Kurs Aktie Borse Enta Us29251m1062 Marketscreener

View recent trades and share price information for Enanta Pharmaceuticals Inc USD001.

Enanta pharmaceuticals aktie. Nettoeinkommen Gewinn und Gewinn pro Aktie Gewinn und EPS sind nützliche Metriken der Profitabilität. Dividiert man den Nettogewinn durch die Gesamtzahl. Is a biotechnology company.

The following information was filed by Enanta Pharmaceuticals Inc ENTA on Monday November 23 2020 as an 8K 202 statement which is an earnings press release pertaining to results of operations and financial condition. Hos Nordnet kan du handle fra 0 kr. Based on an average daily volume of 160300 shares the days-to-cover ratio is presently 67 days.

Its research and development disease targets include respiratory syncytial virus non-alcoholic steatohepatitis SARS-CoV-2 human metapneumovirus and hepatitis B virus. View Enanta Pharmaceuticals ENTA investment stock information. Object moved to here.

So schneidet die Aktie bei den Analysten ab. Shares of Enanta Pharmaceuticals were trading at 9258 as of November 18. Enantas chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus RSV hepatitis B virus HBV SARS-CoV-2 COVID-19 and human metapneumovirus hMPVLearn more about our.

Get the latest Enanta Pharmaceuticals ENTA detailed stock quotes stock data Real-Time ECN charts stats and more. As of October 29th there was short interest totalling 1080000 shares a drop of 321 from the October 14th total of 1590000 shares. If you are a healthcare professional interested in learning more about Enantas clinical trials please contact.

Enanta Pharmaceuticals NASDAQENTA veröffentlicht am Montag den 08. Enanta Pharmaceuticals NASDAQENTA last announced its quarterly earnings results on Thursday August 5th. Download opens in new window July 14 2021.

It produces clinical candidates which targets respiratory syncytial virus RSV hepatitis B virus HBV and non-alcoholic steatohepatitis NASH diseases. FROG price target from 66 to 71. Enanta Pharmaceuticals Inc.

Approximately 61 of the companys shares are short sold. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30 2021. Given that these returns are generally positive long-term.

Klik her for at følge aktiekursen i realtid. Marketed by AbbVie as MAVYRET US and MAVIRET ex-US. Stock Name Country Market Cap PE Ratio.

Enanta has active clinical trials in areas including respiratory syncytial virus RSV hepatitis B virus HBV and in early 2022 will begin a Phase 1 study in SARS-CoV-2 COVID-19. The Company is focused on discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. Is a biotechnology company which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases.

Das Gesamtergebnis auch bekannt als Nettoeinkommen ist gleich den Gesamteinnahmen minus den Gesamtausgaben. Enanta Pharmaceuticals Inc. NASDAQENTA saw a significant drop in short interest in October.

The Company uses chemistry-driven approach and drug discovery capabilities. Enanta Pharmaceuticals to Host Conference Call on August 5 at 430 pm. Fixed-dose combination contains glecaprevir and AbbVies NS5A inhibitor pibrentasvir.

The company offers glecaprevir for the treatment of chronic. Is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus respiratory tract infections intravenous and oral treatments.

Du kan vælge enten at acceptere alle cookies eller kun acceptere nødvendige cookies der. 19 November 2021. Enanta Pharmaceuticals had a negative net.

Køb Enanta Pharmaceuticals Inc. JFrog shares fell 26 to 3801 in pre-market. The latest Enanta Pharmaceuticals Inc USD001 share price.

Enanta Pharmaceuticals Announces the Planned Retirement of Chief Medical Officer Nathalie Adda MD. Zoetis ZTS United States. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report.

Start Enanta Enanta Pharmaceuticals Aktie. Werden Sie kostenlos Mitglied. Enanta Pharmaceuticals Inc a biotechnology company discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Enanta Pharmaceuticals is using its robust chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment. Enanta Pharmaceuticals shares climbed 111 to close at 9737 on Friday. Needham raised JFrog Ltd.

The Company has clinical candidates for the disease targets including respiratory syncytial virus RSV hepatitis B virus HBV. Die Enanta Pharmaceuticals Inc Aktie wird unter der ISIN US29251M1062 an den Börsen Frankfurt München Stuttgart NASDAQ Bats BX World NDB Gettex Tradegate Lang. The firm had revenue of 2162 million during the quarter compared to analysts expectations of 2187 million.

Enanta is committed to developing new treatments for viral infections and liver diseases. Is headquartered in Watertown Massachusetts. So schneidet die Aktie bei den Analysten ab.

Nordnet bruger egne cookies og cookies fra tredjeparter så vi kan tilpasse indhold og annoncer og analysere hvordan websitet bruges. Common Stock ENTA Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Stock quote stock chart quotes analysis advice financials and news for share ENANTA PHARMACEUTICALS INC.

The biotechnology company reported 119 EPS for the quarter topping analysts consensus estimates of 141 by 022. Over the last 52-week period shares are up 9748.

Enanta Aktien News A1t7bj Nachrichten